MedPath

Hydration therapy in preterm jaundice

Phase 2
Not yet recruiting
Conditions
Health Condition 1: P590- Neonatal jaundice associated withpreterm delivery
Registration Number
CTRI/2024/01/061381
Lead Sponsor
Aradhana
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Preterm neonate (29-33 +6) with severe unconjugated hyperbilirubinemia during first two weeks of life.

Exclusion Criteria

Jaundice <24 h, multiple congenital malformation, stage 2 &3 AKI, FiO2 > 40%, symptomatic PDA or CHD, neonatal encephalopathy, TSB level above 5mg/dl of exchange transfusion threshold

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath